Anjali Aryamvally's Profile
B.Tech (Genetic Engineering)
![Anjali Aryamvally Anjali Aryamvally](https://www.medindia.net/images/content-team-medindia/anjali-aryamvally.jpg)
Anjali is an undergraduate in Genetic Engineering from SRM University, Chennai. She is passionate about bringing changes in healthcare through a combination of genetics and social work. Anjali is an avid reader who enjoys writing. Her hobbies include gardening and traveling.
Written / Edited / Medically Reviewed
![Melanocyte Transplantation Restores Original Skin Color In Vitiligo Patients](https://www.medindia.net/health-images/vitiligo-through-melanocyte-transplantation.jpg)
Melanocyte Transplantation Restores Original Skin Color In Vitiligo Patients
MKTP or melanocyte transplantation surgery has long term benefits of restoring pigmentation in vitiligo-affected individuals.
![Parkinson’s Disease Associated With Gastrointestinal Dysfunction](https://www.medindia.net/health-images/parkinson-disease.jpg)
Parkinson’s Disease Associated With Gastrointestinal Dysfunction
Gastrointestinal transit time and motility in persons affected with Parkinson’s disease were evaluated in a study by researchers at Aarhus University, Denmark.
![CRISPR Used to Block Angiogenesis in the Retina](https://www.medindia.net/health-images/crispr-blocks-angiogenesis-in-vivo.jpg)
CRISPR Used to Block Angiogenesis in the Retina
CRISPR was used to edit the vascular endothelial growth factor receptor (VEGFR) 2 which is involved in angiogenesis associated diseases.
![Two New Genes Linked to Development of Rare Neuroendocrine Tumors](https://www.medindia.net/health-images/rare-and-new-genetic-variations-linked-to-neuroendocrine-tumors.jpg)
Two New Genes Linked to Development of Rare Neuroendocrine Tumors
Two new genes; GOT2 and IDH3B, identified to be linked with development of paragangliomas and pheochromocytomas.
![Novel Genetic Screening a Boon to Cancer Immunotherapy](https://www.medindia.net/health-images/crispr-cas9-screening-genes-for-immunotherapy.jpg)
Novel Genetic Screening a Boon to Cancer Immunotherapy
A CRISPR-Cas9 screening system was developed to identify new gene targets for cancer immunotherapy.